LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.82 | 17.25 | 952 | 800 | 1.1893 | 1.0636 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.82 | 17.25 | 153 | 800 | 0.1911 | 0.4833 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.82 | 17.25 | 1076 | 800 | 1.3442 | 1.1098 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.79 | 17.25 | 2 | 1001 | 0.0020 | -0.3077 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.79 | 17.25 | 997 | 1001 | 0.9954 | 0.9984 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.79 | 17.25 | 448 | 1001 | 0.4473 | 0.7434 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.79 | 17.25 | 1151 | 1001 | 1.1491 | 1.0480 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.76 | 17.25 | 9 | 1193 | 0.0075 | -0.1010 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.76 | 17.25 | 1026 | 1193 | 0.8596 | 0.9511 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.76 | 17.25 | 555 | 1193 | 0.4650 | 0.7645 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.76 | 17.25 | 1209 | 1193 | 1.0129 | 1.0042 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.73 | 17.25 | 4 | 1290 | 0.0031 | -0.2093 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.73 | 17.25 | 1074 | 1290 | 0.8324 | 0.9419 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.73 | 17.25 | 732 | 1290 | 0.5674 | 0.8259 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.73 | 17.25 | 1274 | 1290 | 0.9874 | 0.9959 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.70 | 17.25 | 5 | 1466 | 0.0034 | -0.1757 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.70 | 17.25 | 1162 | 1466 | 0.7923 | 0.9286 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.70 | 17.25 | 890 | 1466 | 0.6068 | 0.8500 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.70 | 17.25 | 1349 | 1466 | 0.9197 | 0.9741 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.67 | 17.25 | 11 | 1653 | 0.0067 | -0.0661 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.67 | 17.25 | 1231 | 1653 | 0.7446 | 0.9124 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.67 | 17.25 | 982 | 1653 | 0.5940 | 0.8478 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.67 | 17.25 | 1417 | 1653 | 0.8572 | 0.9537 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.64 | 17.25 | 13 | 1887 | 0.0069 | -0.0409 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.64 | 17.25 | 1306 | 1887 | 0.6920 | 0.8942 | MN20160310_N02 | C22 |